124 related articles for article (PubMed ID: 35639628)
1. Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
Behl A; Sarwalia P; Kumar S; Behera C; Mintoo MJ; Datta TK; Gupta PN; Chhillar AK
Mol Pharm; 2022 Jul; 19(7):2429-2440. PubMed ID: 35639628
[TBL] [Abstract][Full Text] [Related]
2. A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer
Zhang L; Zhu J; Hou Y; Li C; Liu H
J Cancer Res Ther; 2021 Dec; 17(7):1702-1708. PubMed ID: 35381742
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells.
Behera C; Kaur Sandha K; Banjare N; Kumar Shukla M; Mudassir Ali S; Singh M; Gupta PN
Int J Pharm; 2024 Jan; 649():123599. PubMed ID: 37992978
[TBL] [Abstract][Full Text] [Related]
4. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
Liu D; Zhang W; Liu X; Qiu R
Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
6. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
[TBL] [Abstract][Full Text] [Related]
7. Comment on: "Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy".
Tian T
Mol Pharm; 2023 Feb; 20(2):1447-1448. PubMed ID: 36576337
[No Abstract] [Full Text] [Related]
8. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer.
Behl A; Solanki S; Paswan SK; Datta TK; Saini AK; Saini RV; Parmar VS; Thakur VK; Malhotra S; Chhillar AK
J Polym Environ; 2023; 31(3):999-1018. PubMed ID: 36405816
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of polymer-based self-assembly nanocarriers loaded with a crizotinib and gemcitabine: potential therapeutics for the treatment of endometrial cancer.
Yang J; Guo H; Lei J; Zhang S; Zhang S; Bai J; Li S
J Biomater Sci Polym Ed; 2022 Jan; 33(1):20-34. PubMed ID: 34602004
[TBL] [Abstract][Full Text] [Related]
13. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.
Zhang L; Hou Y; Li C; Liu H; Wang Y
Arab J Gastroenterol; 2022 Nov; 23(4):263-269. PubMed ID: 35922259
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
17. Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells.
Hu C; Du W
Aging (Albany NY); 2020 Nov; 12(24):25767-25777. PubMed ID: 33232271
[TBL] [Abstract][Full Text] [Related]
18. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
[TBL] [Abstract][Full Text] [Related]
19. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
Xiao Y; Gao Y; Li F; Deng Z
Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
